A Study in Adults to Learn About Inherited Alpha-1 Antitrypsin Deficiency (AATD) and AATD Related Liver Problems | MicrobiomeTrials← Back to trialsNCT06512454
A Study in Adults to Learn About Inherited Alpha-1 Antitrypsin Deficiency (AATD) and AATD Related Liver Problems
RecruitingOBSERVATIONAL
Trial Details
Start: 2024-09-25Est. Completion: 2031-12-31
Enrollment target: 500 participants Locations- University of Florida, Gainesville, Florida, United States
- University of South Carolina, Charleston, South Carolina, United States
- Vanderbilt University Medical Center, Nashville, Tennessee, United States
- Vienna General Hospital (AKH Wien), Vienna, Austria
- Universitätsklinikum Aachen, Aachen, Germany
- Beaumont Hospital, Dublin, Ireland
- Hospital Universitari Vall d'Hebron, Barcelona, Spain
- Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom
Other microbiome trials you might be interested in
Alpha 1 Antitrypsin Deficiency
This is a Phase 1, open-label, single ascending dose (SAD) and multiple dose (MD) study of AIR-001 in participants with …
Melbourne, AustraliaEst. completion Nov 2028
Alpha-1-antitrypsin DeficiencyEmphysemaArtificial Intelligence (AI)Predictive Learning ModelsMortality PredictionLung Transplantation
Emphysema linked to alpha-1-antitrypsin deficiency (DAAT): towards a better prediction of risks Emphysema caused by alph…
Bron, France
Est. completion Mar 16, 2031